microdosing glp 1 tirzepatide People Are Microdosing Weight-Loss Drugs
Description
Supplied
It highlights emerging evidence, safety considerations, and equity challenges that position GLP-1 RAs as a promising public health strategy for this high-risk population.
Results from a clinical trial suggest that semaglutide, the substance in Ozempic and Wegovy, can halt and even reverse a common liver disease that affects millions worldwide.
Larger randomized controlled trials with long-term follow-up are necessary to confirm these associations and evaluate the risk-benefit ratios
The 50-year-old The Big Bang Theory alum wrote a piece for The Free
